Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
Feb 02, 2026 20:00 HKT |  |
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT |  |
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT |  |
|
康哲藥業（867.HK/8A8.SG）：磷酸蘆可替尼乳膏獲批 為中國批准的首款且唯一白癜風靶向藥
Jan 30, 2026 15:22 HKT |  |
|
康哲药业（867.HK/8A8.SG）：磷酸芦可替尼乳膏获批 为中国批准的首款且唯一白癜风靶向药
Jan 30, 2026 15:13 HKT | |
|
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Jan 29, 2026 20:57 HKT | |
|
Hong Kong Tech Firms Win Big at CES 2026 with Frontier Tech Innovations to Draw Global Buyer Interest
Jan 08, 2026 19:31 HKT |  |
|
吉因加啟動港股IPO：AI驅動全鏈條精準醫療 構築差異化技術壁壘
Dec 30, 2025 20:14 HKT | |
|
吉因加启动港股IPO：AI驱动全链条精准医疗 构筑差异化技术壁垒
Dec 30, 2025 19:28 HKT | |
|
Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa
Dec 24, 2025 12:20 HKT |  |
|
青岛国资+双管线驱动！华芢生物（02396.HK）破局PDGF稀缺赛道 锚定国配核心机遇
Dec 16, 2025 10:39 HKT |  |
|
青島國資+雙管線驅動！華芢生物（02396.HK）破局PDGF稀缺賽道 錨定國配核心機遇
Dec 16, 2025 10:39 HKT | |
|
康哲藥業（867.HK/8A8.SG）：創新藥口服JAK1抑制劑Povorcitinib在中國獲納入「突破性治療品種」
Dec 16, 2025 08:07 HKT | |
|
康哲药业（867.HK/8A8.SG）：创新药口服JAK1抑制剂Povorcitinib在中国获纳入"突破性治疗品种"
Dec 16, 2025 08:06 HKT | |
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00 HKT | |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT | |
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT | |
|
康哲藥業（0867）抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理
Dec 11, 2025 20:01 HKT | |
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT | |
|
康哲药业（0867）抗急性缺血性卒中创新药注射用Y-3中国NDA获受理
Dec 11, 2025 19:53 HKT | |
|